Search clinical trials for: Carfilzomib
Total 243 results
-
SanofiNot yet recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
CelgeneNot yet recruitingMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Peking University First HospitalRecruitingMultiple Myeloma | Renal InjuryChina
-
AbbVieNot yet recruiting
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada
-
Dong-A University HospitalNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
University of ChicagoGlaxoSmithKline; AmgenRecruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States
-
SanofiRecruitingRelapsed/Refractory Multiple MyelomaCzechia, Japan, Australia, Brazil, Greece, Portugal
-
Universitätsklinikum Hamburg-EppendorfGemeinsamer Bundesausschuss (G-BA); Staburo GmbHRecruiting
-
PfizerRecruiting
-
Thomas LundRecruiting
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Japan, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Netherlands, Poland, Austria, Portugal, Greece, India
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
Samsung Medical CenterRecruiting
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | ISS Stage III Plasma Cell MyelomaUnited States
-
Samsung Medical CenterRecruiting
-
Dong-A University HospitalAmgenNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaKorea, Republic of, Russian Federation, Spain, United States, Germany, Greece, Belgium, Denmark, France, Ukraine, China
-
University of Alabama at BirminghamRecruitingMultiple MyelomaUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
PETHEMA FoundationAdknoma Health ResearchRecruitingRelapsed Multiple MyelomaSpain
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, United Kingdom, Netherlands, France, Australia
-
University Hospital, LimogesRecruitingHematological DiseasesFrance
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; PPD; Rho Federal Systems Division, Inc.; Immune Tolerance...RecruitingHighly Sensitized Prospective Kidney Transplant RecipientsUnited States
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, United Kingdom, Canada, Brazil, New Zealand
-
National Cancer Institute (NCI)Janssen Scientific Affairs, LLCRecruiting
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
University of WashingtonGenzyme, a Sanofi CompanyRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of ChicagoRecruitingMultiple Myeloma | Cardiotoxicity | Dyspnea | Shortness of BreathUnited States
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryIsrael
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsRecruiting
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, Austria, Belgium, China, France, Hong Kong, Italy, Japan, Puerto Rico, Russian Federation, Spain, Switzerland, United Arab Emirates, United Kingdom, Kuwait, Saudi Arabia, Netherlands, Taiwan
-
Cairo UniversityNot yet recruitingIVF | Endometrial ReceptivityEgypt
-
University of MiamiAmgen; Janssen PharmaceuticalsRecruitingMultiple MyelomaUnited States, Sweden
-
Christian BuskeAmgen; Janssen, LPRecruitingWaldenstrom MacroglobulinemiaAustria, Germany, Greece
-
Andrew Yee, MDJanssen Research & Development, LLC; AmgenRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse | Multiple Myeloma in RelapseUnited States
-
CelgeneRecruitingMultiple MyelomaUnited States, Germany, Canada, France, Greece, Italy, Spain, Denmark, Czechia
-
Hackensack Meridian HealthAmgenRecruitingMultiple MyelomaUnited States
-
Loyola UniversityAmgenRecruiting
-
University of ChicagoRecruiting
-
University of ChicagoJanssen Scientific Affairs, LLC; AmgenRecruitingMultiple Myeloma | MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States